# Cognitive Protection - Dexmedetomidine and Cognitive Reserve

> **NCT00455143** · PHASE4 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 27 (actual)

## Conditions studied

- Postoperative Delirium
- PD
- Postoperative Cognitive Dysfunction
- POCD

## Interventions

- **DRUG:** Precedex (Dexmedetomidine)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00455143
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Pilot study initiated to provide support data for main grant GCO 06-0217 funded. only baseline characteristic data collected. no results for this study.
- **Last updated:** 2019-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00455143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00455143, "Cognitive Protection - Dexmedetomidine and Cognitive Reserve". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00455143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*